Lantheus Earnings Reports

Lantheus reported worldwide revenue of $391.1 million for Q4 2024, a 10.5% increase compared to the same period in 2023. PYLARIFY achieved record net sales, but the company posted a GAAP net loss of $11.8 million for the quarter. Adjusted earnings per share were $1.59, reflecting continued growth in radiopharmaceuticals.

Lantheus reported a strong Q3 2024 with an 18.4% increase in worldwide revenue to $378.7 million. GAAP EPS was $1.79, while adjusted EPS was $1.70. The company is narrowing its full-year 2024 revenue and EPS guidance towards the higher end of previous estimates.

Lantheus reported a strong second quarter with worldwide revenue of $394.1 million, a 22.5% increase from Q2 2023. Growth was primarily driven by PYLARIFY and DEFINITY. The company completed three strategic transactions to expand its radiopharmaceutical pipeline. GAAP fully diluted earnings per share were $0.88, while adjusted fully diluted earnings per share were $1.80.

Lantheus Holdings, Inc. reported a strong first quarter in 2024, with worldwide revenue increasing by 23.0% to $370.0 million. GAAP fully diluted net income per share was $1.87, compared to a loss of $0.04 in the same period last year. The company has raised its full-year 2024 revenue and earnings guidance.

Lantheus Holdings, Inc. reported a strong Q4 2023 with worldwide revenue of $354.0 million, a 34.5% increase compared to Q4 2022. GAAP net income was $103.4 million, or $1.47 per fully diluted share, compared to a net loss in the prior year. Adjusted fully diluted EPS was $1.75, a 28.0% increase year-over-year. Free cash flow was $100.2 million.

Lantheus reported strong Q3 2023 financial results, with a significant increase in worldwide revenue and GAAP net income compared to the same period last year. The company's performance was driven by its commercial portfolio and pipeline progress.

Lantheus reported a strong second quarter in 2023, with worldwide revenue of $321.7 million, representing a 43.8% increase from the prior year period. GAAP net income was $94.1 million, or $1.33 per fully diluted share, compared to $43.1 million, or $0.61 per fully diluted share, in the prior year period. Adjusted fully diluted net income per share was $1.54, compared to $0.89 in the prior year period.

Lantheus Holdings, Inc. reported a worldwide revenue increase of 44.0% year-over-year, reaching $300.8 million. The company experienced a GAAP net loss of $2.8 million, or $0.04 per fully diluted share, but achieved an adjusted fully diluted net income per share of $1.47. Free cash flow was $99.3 million, marking a significant increase from the prior year period.

Lantheus reported a substantial increase in revenue and a return to profitability for Q4 2022. Worldwide revenue increased by 103.1% compared to the prior year period, driven primarily by the strong performance of PYLARIFY. The company achieved an adjusted fully diluted EPS of $1.37, a significant increase from $0.25 in the prior year period.

Lantheus reported a significant increase in revenue and a shift to net income in Q3 2022. Worldwide revenue increased by 134.4% compared to the prior year period, and GAAP net income was $61.2 million, compared to a net loss in the prior year period. The company also provided Q4 2022 revenue and adjusted diluted EPS guidance and increased full year guidance.

Lantheus reported a worldwide revenue of $223.7 million for Q2 2022, a 121.4% increase from the prior year period. GAAP net income was $43.1 million, or $0.61 per fully diluted share, compared to a net loss of $26.7 million, or $0.39 per fully diluted share, in the prior year period. Adjusted fully diluted earnings per share were $0.89, compared to $0.11 for the same period last year. Free cash flow was $68.3 million, representing an increase of approximately $45.0 million from the prior year period.

Lantheus Holdings, Inc. reported a significant increase in revenue and earnings for the first quarter of 2022. Worldwide revenue increased by 125.8% compared to the prior year, with a substantial rise in GAAP net income and adjusted fully diluted EPS. The company's performance was primarily driven by rapidly increasing PYLARIFY sales and strategic partnerships.

Lantheus Holdings, Inc. reported a worldwide revenue of $101.1 million for Q2 2021, a 53.1% increase compared to the prior year period. The company's GAAP net loss was $26.7 million, or $0.39 per fully diluted share, while adjusted fully diluted EPS was $0.11. Net cash from operating activities was $25.9 million, and free cash flow was $23.2 million.

Lantheus Holdings, Inc. reported a 2.0% increase in worldwide revenue, reaching $92.5 million for Q1 2021. Net income increased to $9.0 million, with GAAP EPS at $0.13. Free cash flow was $7.3 million for the quarter.

Lantheus Holdings, Inc. reported a 5.4% increase in worldwide revenue for the fourth quarter of 2020, totaling $94.2 million, compared to $89.3 million in the prior year period. The company's net loss for the quarter was $3.4 million, or $0.05 per fully diluted share, compared to a net income of $10.5 million, or $0.26 per fully diluted share, for the fourth quarter of 2019.

Lantheus Holdings, Inc. reported a 3.2% increase in worldwide revenue for Q3 2020, totaling $88.5 million. However, the company experienced a net loss of $6.4 million, or $(0.10) per share, compared to a net income of $4.9 million, or $0.12 per share, in Q3 2019. Adjusted EPS was $0.04, down from $0.28 in the prior year period. Free cash flow for the quarter was $4.8 million.

Lantheus Holdings, Inc. reported a decrease in worldwide revenue of 23.0% compared to the prior year period. The company had a net loss of $7.0 million, or $(0.16) per fully diluted share, as compared to net income of $6.4 million, or $0.16 per fully diluted share for the second quarter of 2019. They completed the acquisition of Progenics in June.

Lantheus Holdings, Inc. reported a 4.8% increase in worldwide revenue for Q1 2020, totaling $90.7 million. Net income decreased by 66.5% to $3.3 million, with GAAP diluted EPS down 66.7% to $0.08. However, adjusted diluted EPS increased by 26.1% to $0.36. The company's free cash flow was $6.7 million. Due to the uncertain impact of COVID-19, Lantheus has withdrawn its 2020 guidance.

Lantheus Holdings, Inc. reported a 3.6% increase in worldwide revenue for the fourth quarter of 2019, totaling $89.3 million. Net income for the quarter was $10.5 million, a decrease of 21.4% compared to the same period in 2018. Adjusted fully diluted earnings per share were $0.34, representing a 19.0% increase over the prior year period. The company provided first quarter and full year 2020 revenue and adjusted fully diluted earnings per share guidance.